SCHEMBL6856471

SCHEMBL6856471

C=C(C)C(=O)OCC1CSC(c2ccc(Br)cc2)S1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
LMNA P02545 2/20 0.32
ATM Q13315 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
MAPT P10636 3/20 0.31
HTT P42858 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209650 0.94 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL6861810 0.89 CA1 (0.42) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL6862847 0.88 ALDH1A1 (0.38) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL7041104 0.88 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL6860789 0.87 GAA (0.39) ALDH1A1TSHRCA1CA2KMT2A
SCHEMBL6860962 0.86 ALDH1A1 (0.36) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL6861219 0.86 ALDH1A1 (0.36) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL5209184 0.85 ALDH1A1 (0.38) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL5209148 0.84 ALDH1A1 (0.38) ALDH1A1CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL6862967 0.84 MMP2 (0.40) ALDH1A1KMT2AATMHTTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6794471-B2 OF A HYDROXYHYDROCARBYL- OR MERCAPTOHYDROCARBYL- DITHIOLANE; CURED OPTICAL ARTICLE FORMED BY PHOTOPOLYMERIZING THE ACRYLATE MITSUI CHEMICALS, INC. (JP) 2004-09-21 US disclosed
EP-1193264-B1 Acrylic ester compound and usage thereof MITSUI CHEMICALS INC (JP) 2004-03-31 EP disclosed
US-20020061995-A1 Acrylic ester compound and usage thereof MITSUI CHEMICALS, INC. (JP) 2002-05-23 US disclosed
EP-1193264-A1 Acrylic ester compound and usage thereof Mitsui Chemicals, Inc. (JP) 2002-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061995-A1 Acrylic ester compound and usage thereof ASS1, HAT1, EIF2B1 ALDH1A1 132/4885CYP3A4 934/4885CYP2D6 2616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.